Hydra Active Pharma Sciences Profile
Key Indicators
- Authorised Capital ₹ 146.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 121.05 Cr
as on 16-11-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 460.00 Cr
as on 16-11-2024
- Revenue 40.53%
(FY 2023)
- Profit 67.41%
(FY 2023)
- Ebitda 47.21%
(FY 2023)
- Net Worth 0.95%
(FY 2023)
- Total Assets 1.25%
(FY 2023)
About Hydra Active Pharma Sciences
The Corporate was formerly known as Tenshi Active Pharma Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 146.00 Cr and a paid-up capital of Rs 121.05 Cr.
The company currently has active open charges totaling ₹460.00 Cr.
The Key Managerial Personnel (KMP) at Hydra Active Pharma Sciences Private Limited India is Geethika Jayasree as COMPANY SECRETARY. Ramaprasad Sriraman and Chandrappa Seetharamaiah serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC365641
- Company No.
098276
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hydra Active Pharma Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geethika Jayasree  | Company Secretary | 05-May-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramaprasad Sriraman | Director | 06-Dec-2016 | Current |
| Chandrappa Seetharamaiah | Director | 06-Dec-2016 | Current |
Financial Performance of Hydra Active Pharma Sciences.
Hydra Active Pharma Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.53% increase. The company also saw a substantial improvement in profitability, with a 67.41% increase in profit. The company's net worth moved up by a moderate rise of 0.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hydra Active Pharma Sciences?
In 2023, Hydra Active Pharma Sciences had a promoter holding of 97.91% and a public holding of 2.09%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skanray Healthcare Global Private LimitedActive 11 years 9 monthsRamaprasad Sriraman and Chandrappa Seetharamaiah are mutual person
Pronomz Ventures LlpActive 13 years 11 monthsRamaprasad Sriraman and Chandrappa Seetharamaiah are mutual person
- Tenshi Ventures LlpActive 10 years 10 months
Ramaprasad Sriraman and Chandrappa Seetharamaiah are mutual person
- Tenshi Pharmaceuticals Private LimitedActive 8 years 6 months
Chandrappa Seetharamaiah is a mutual person
Charges (Loans)
₹460.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 460.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2024 | Others | ₹300.00 Cr | Open |
| 28 Jun 2024 | Others | ₹40.00 Cr | Open |
| 11 Jan 2024 | Others | ₹35.00 Cr | Open |
| 11 Jan 2024 | Others | ₹25.00 Cr | Open |
| 11 Jan 2024 | Others | ₹25.00 Cr | Open |
How Many Employees Work at Hydra Active Pharma Sciences?
Unlock and access historical data on people associated with Hydra Active Pharma Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hydra Active Pharma Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hydra Active Pharma Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
